Bernstein Initiates Coverage On Exact Sciences with Outperform Rating, Announces Price Target of $83
Portfolio Pulse from Benzinga Newsdesk
Bernstein analyst Eve Burstein has initiated coverage on Exact Sciences (NASDAQ:EXAS) with an Outperform rating and a price target of $83.
September 28, 2023 | 10:36 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exact Sciences has been given an Outperform rating and a price target of $83 by Bernstein analyst Eve Burstein.
The Outperform rating and price target of $83 by Bernstein analyst Eve Burstein indicates a positive outlook for Exact Sciences. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100